Reichert Brings Cutting-Edge Eye Care Tech to Vision Expo East 2025


 
As eye care rapidly evolves, Vision Expo East 2025 is the place to see where innovation meets clinical excellence — and Reichert is leading the charge. At booth F2201, practitioners can experience hands-on demos of Reichert’s latest breakthroughs in tonometry, digital refraction, and dry eye diagnostics. Of particular note is the new Tono-Vera® Tonometer, which simplifies intraocular pressure readings with its patented ActiView™ Positioning System. Reichert is also showcasing its premium Phoroptor® VRx Digital Refraction System alongside the intuitive SightChek® Digital Phoroptor, offering powerful options for practices of all sizes. With dry eye disease on the rise, their suite of evaluation and therapy devices helps practices meet growing demand. Visitors can also explore the Ocular Response Analyzer® G3, a game-changer in glaucoma management with its unique Corneal Hysteresis and IOPcc metrics. Plus, for those who stop by for a demo, there’s a chance to win a $1,000 Visa gift card — a rewarding way to explore the future of vision care.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…